Breaking News

Sartorius Joins DFKI to Support AI for Advanced Medicines

Conducting research on deep learning algorithms for modeling of biological systems and for optimization of biopharmaceutical production processes.

By: Contract Pharma

Contract Pharma Staff

Sartorius has joined the group of shareholders of the German Research Center for Artificial Intelligence (DFKI). The life science group and DFKI have been working together in a joint research lab on the development of future-focused tools and AI applications for the production of advanced medications. Sartorius and DFKI are currently conducting research on deep learning algorithms and methods for image recognition of cells and organoids, analysis and modeling of biological systems, and for s...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters